Trial Profile
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease: Prospective, Randomized, Controlled Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 09 Jun 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 09 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Oct 2007 Status changed from recruiting to in progress.